• Female

Drs. E.R. Zaaijer

Position: PhD student
Main activities: Research
Specialisation: Neuroimaging
Focus of research:

Extended release depot naltrexone mechanism of action in heroin dependent patients using fMRI and SPECT

AMC themes: Neurological & Psychiatric Disorders
Departments: Nuclear Medicine, Psychiatry: Adult Psychiatry
Zaaijer E R, Goudriaan AE, Koeter MWJ, Booij J, Wim van den Brink (red.) W, Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands. SUBST USE MISUSE 2016;51 (14):1905-1911 [PubMed]
Zaaijer ER. Chasing the dragon away: Personality as a protective factor and extended-release naltrexone as a treatment for heroin dependence. S.l.: s.n.; 2015. 117p. ISBN 978-94-6182-577-3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Booij J, van den Brink W; copromotor(s): Goudriaan AE)
Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J, Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats. J PSYCHOPHARMACOL 2015;29 (3):344-348 [PubMed]
Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MWJ, van den Brink W, Booij J, Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. PSYCHOPHARMACOLOGY 2015;232 (14):2597-2607 [PubMed]
Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MWJ, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W, Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. DRUG ALCOHOL DEPEN 2014;145:101-105 [PubMed]
Key publications

All Publications

Research programmes
Other research related activities
  • None reported
Current research funding
  • None reported